The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.

Analysts called a stock sell-off at Embecta "unwarranted" and believe the company is moving in the right direction despite recent challenges.

There are 38 million Americans with diabetes, and 10% percent of those with diabetes have Type 1. Type 1 is usually diagnosed ...

Irvine-based medical device company Beta Bionics Inc. on Jan. 6 filed an S-1 with the Securities and Exchange Commission to ...

Elden Ring and Bloodborne developer FromSoftware's parent company Kadokawa has a bursting portfolio of video games, anime, ...

If perpetually cold hands and feet weren’t clear tip-offs that we’re now in winter’s grasp, perhaps a flurry of dry, flaky skin has driven it home. Rough, itchy patches are ...

Patch Tuesday is Microsoft’s monthly update day for fixing vulnerabilities. Learn its purpose, benefits, and how it enhances system security. On the second Tuesday of each month, Microsoft and ...

In the Western U.S., extreme wildfires are damaging tribal lands. Climate change has only made the situation more dire.